| pubmed-article:11690683 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11690683 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:11690683 | lifeskim:mentions | umls-concept:C0005684 | lld:lifeskim |
| pubmed-article:11690683 | lifeskim:mentions | umls-concept:C0225340 | lld:lifeskim |
| pubmed-article:11690683 | lifeskim:mentions | umls-concept:C0376515 | lld:lifeskim |
| pubmed-article:11690683 | lifeskim:mentions | umls-concept:C0079419 | lld:lifeskim |
| pubmed-article:11690683 | lifeskim:mentions | umls-concept:C1514474 | lld:lifeskim |
| pubmed-article:11690683 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:11690683 | pubmed:dateCreated | 2001-11-5 | lld:pubmed |
| pubmed-article:11690683 | pubmed:abstractText | In a recent study on patients with transitional cell cancer of the bladder treated with curative radiotherapy following TUR-T, we demonstrated that a low apoptotic index and p53 positivity were associated with poor local control. The purpose of this study was to assess the prognostic significance of additional markers implicated in regulation of cell cycle and apoptosis. | lld:pubmed |
| pubmed-article:11690683 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11690683 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11690683 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11690683 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11690683 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11690683 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11690683 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11690683 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11690683 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11690683 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11690683 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11690683 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:11690683 | pubmed:issn | 0167-8140 | lld:pubmed |
| pubmed-article:11690683 | pubmed:author | pubmed-author:HartA AAA | lld:pubmed |
| pubmed-article:11690683 | pubmed:author | pubmed-author:BartelinkHH | lld:pubmed |
| pubmed-article:11690683 | pubmed:author | pubmed-author:MoonenL MLM | lld:pubmed |
| pubmed-article:11690683 | pubmed:author | pubmed-author:GalleeM PMP | lld:pubmed |
| pubmed-article:11690683 | pubmed:author | pubmed-author:LOT YTY | lld:pubmed |
| pubmed-article:11690683 | pubmed:author | pubmed-author:ten BoschCC | lld:pubmed |
| pubmed-article:11690683 | pubmed:author | pubmed-author:VerheijMM | lld:pubmed |
| pubmed-article:11690683 | pubmed:author | pubmed-author:ZerpS FSF | lld:pubmed |
| pubmed-article:11690683 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11690683 | pubmed:volume | 61 | lld:pubmed |
| pubmed-article:11690683 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11690683 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11690683 | pubmed:pagination | 169-75 | lld:pubmed |
| pubmed-article:11690683 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:meshHeading | pubmed-meshheading:11690683... | lld:pubmed |
| pubmed-article:11690683 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11690683 | pubmed:articleTitle | Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53. | lld:pubmed |
| pubmed-article:11690683 | pubmed:affiliation | Department of Radiotherapy, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX The, Amsterdam, Netherlands. | lld:pubmed |
| pubmed-article:11690683 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11690683 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11690683 | lld:pubmed |
